These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16816548)

  • 1. [Ecstasy toxicity].
    Reingardiene D
    Medicina (Kaunas); 2006; 42(6):519-23. PubMed ID: 16816548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agony and ecstasy: a review of MDMA effects and toxicity.
    Burgess C; O'Donohoe A; Gill M
    Eur Psychiatry; 2000 Aug; 15(5):287-94. PubMed ID: 10954872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine.
    Traub SJ; Hoffman RS; Nelson LS
    J Urban Health; 2002 Dec; 79(4):549-55. PubMed ID: 12468674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
    Campbell GA; Rosner MH
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1852-60. PubMed ID: 18684895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN; Spigset O; Slørdal L
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity of MDMA: Main effects and mechanisms.
    Costa G; Gołembiowska K
    Exp Neurol; 2022 Jan; 347():113894. PubMed ID: 34655576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use.
    Ajaelo I; Koenig K; Snoey E
    Acad Emerg Med; 1998 Aug; 5(8):839-40. PubMed ID: 9715247
    [No Abstract]   [Full Text] [Related]  

  • 8. MDMA and serotonin: based on two cases.
    Garcia Cabeza I; Zabala A; Soto-Montenegro ML; Arango C
    Actas Esp Psiquiatr; 2005; 33(5):339-42. PubMed ID: 16155817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How MDMA's pharmacology and pharmacokinetics drive desired effects and harms.
    Michael White C
    J Clin Pharmacol; 2014 Mar; 54(3):245-52. PubMed ID: 24431106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered states: the clinical effects of Ecstasy.
    Cole JC; Sumnall HR
    Pharmacol Ther; 2003 Apr; 98(1):35-58. PubMed ID: 12667887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute and long-term effects of ecstasy].
    Salzmann J; Marie-Claire C; Noble F
    Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is the anxiety about Ecstasy justified?].
    Möller-Nehring E; Luderer HJ
    Fortschr Med; 1997 Mar; 115(7):28, 31-2, 34. PubMed ID: 9173018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific neurotoxicity of chronic use of ecstasy.
    Obrocki J; Schmoldt A; Buchert R; Andresen B; Petersen K; Thomasius R
    Toxicol Lett; 2002 Feb; 127(1-3):285-97. PubMed ID: 12052669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New Drugs: Ectasy and Gamma-Hydroxy-Butyrate (GHB)].
    Feldman N; Croquette-Krokar M
    Vertex; 2002; 13(47):5-8. PubMed ID: 11967570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of mild hyponatraemia in females using ecstasy at a rave party.
    van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium
    Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On ecstasy].
    Boulu R
    Ann Pharm Fr; 2003 May; 61(3):155-6. PubMed ID: 12714927
    [No Abstract]   [Full Text] [Related]  

  • 19. Ecstasy-associated acute severe hyponatremia and cerebral edema: a role for osmotic diuresis?
    Ghatol A; Kazory A
    J Emerg Med; 2012 Jun; 42(6):e137-40. PubMed ID: 19500936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.
    Silins E; Copeland J; Dillon P
    Aust N Z J Psychiatry; 2007 Aug; 41(8):649-55. PubMed ID: 17620161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.